{"id":"perflubutane","rwe":[{"pmid":"41574786","year":"2026","title":"Efficacy of Contrast-Enhanced Endoscopic Ultrasound in the Diagnosis of Gallbladder Tumor: A Retrospective Multicenter Cohort Study.","finding":"","journal":"Journal of hepato-biliary-pancreatic sciences","studyType":"Clinical Study"},{"pmid":"41515615","year":"2026","title":"Primary Hepatic Squamous Cell Carcinoma.","finding":"","journal":"Diagnostics (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41371675","year":"2025","title":"[Diffuse intrahepatic cholangiocarcinoma with diverse imaging findings].","finding":"","journal":"Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology","studyType":"Clinical Study"},{"pmid":"40764793","year":"2025","title":"Perfluorobutane CEUS for early-stage cervical lymphoma: diagnostic value of the postvascular phase starfield sign.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"40437838","year":"2025","title":"Differentiating between hepatocellular carcinoma and its mimickers using contrast-enhanced ultrasound with perflubutane microbubbles.","finding":"","journal":"Expert review of medical devices","studyType":"Clinical Study"}],"tags":[{"label":"perflubutane","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V08DA06","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_3","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"perfluorobutane","offLabel":[],"synonyms":["perflubutane","perfluorobutane","Decafluoro-butane","perflubutane polymer microspheres"],"timeline":[],"approvals":[],"brandName":"Perfluorobutane","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"perflubutane","explanation":"Imagine a special gas that can be breathed in and then seen on a scan. This gas, perflubutane, is used to help doctors see inside the lungs and diagnose problems. It's like a temporary, invisible dye that helps doctors get a clearer picture of what's going on inside the body.","oneSentence":"Perflubutane works by dissolving in the bloodstream and accumulating in the lungs, allowing for imaging and diagnosis of lung conditions.","technicalDetail":"Perflubutane is a perfluorocarbon that dissolves in the bloodstream and is taken up by the lungs, where it can be detected using magnetic resonance imaging (MRI) or other imaging modalities, allowing for the visualization of lung structure and function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3999","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=PERFLUBUTANE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PERFLUBUTANE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:17:08.135872","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:26.046815+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"perflutren","drugSlug":"perflutren","fdaApproval":"2001-07-31","patentExpiry":"May 4, 2037","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"sulfur hexafluoride","drugSlug":"sulfur-hexafluoride","fdaApproval":"2014-10-10","patentExpiry":"May 15, 2039","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"perflubutane","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"perflutren","brandName":"perflutren","genericName":"perflutren","approvalYear":"2001","relationship":"same-class"},{"drugId":"sulfur-hexafluoride","brandName":"sulfur hexafluoride","genericName":"sulfur hexafluoride","approvalYear":"2014","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04821284","phase":"PHASE1,PHASE2","title":"Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Flemming Forsberg","startDate":"2021-12-06","conditions":["Locally Advanced Pancreatic Ductal Adenocarcinoma","Metastatic Pancreatic Ductal Adenocarcinoma","Stage II Pancreatic Cancer AJCC v8","Stage IIA Pancreatic Cancer AJCC v8","Stage IIB Pancreatic Cancer AJCC v8","Stage III Pancreatic Cancer AJCC v8","Stage IV Pancreatic Cancer AJCC v8","Unresectable Pancreatic Ductal Adenocarcinoma"],"enrollment":120,"completionDate":"2026-02-28"},{"nctId":"NCT07145801","phase":"PHASE2","title":"Y-90 Treatment Response Using Transarterial Radioembolization","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-09-11","conditions":["HCC","Hepatocellular Carcinoma","Liver Cancer","Hepatic Neoplasm","Primary Liver Cancer","Liver Neoplasm"],"enrollment":30,"completionDate":"2027-06-30"},{"nctId":"NCT05105087","phase":"EARLY_PHASE1","title":"Gynecological Sentinel Lymph Nodes CEUS","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2022-04-28","conditions":["Cervical Carcinoma","Malignant Female Reproductive System Neoplasm","Vaginal Carcinoma","Vulvar Carcinoma"],"enrollment":9,"completionDate":"2025-01-29"},{"nctId":"NCT03578224","phase":"EARLY_PHASE1","title":"Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2018-09-06","conditions":["Esophagus"],"enrollment":35,"completionDate":"2022-08-25"},{"nctId":"NCT04720456","phase":"PHASE2","title":"SHAPE of Portal Hypertension in Children","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-11-03","conditions":["Hypertension, Portal"],"enrollment":120,"completionDate":"2025-08"},{"nctId":"NCT02733029","phase":"PHASE2","title":"Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2018-05-30","conditions":["Renal Transplant Rejection"],"enrollment":8,"completionDate":"2023-02-01"},{"nctId":"NCT02652923","phase":"PHASE1,PHASE2","title":"Contrast Ultrasound Detection of Sentinel Lymph Nodes","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2016-01-01","conditions":["Breast Cancer"],"enrollment":98,"completionDate":"2022-01-12"},{"nctId":"NCT05068076","phase":"NA","title":"Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-10-01","conditions":["Hepatocellular Carcinoma","Microwave Ablation"],"enrollment":21,"completionDate":"2021-12-16"},{"nctId":"NCT04847726","phase":"NA","title":"Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2020-06-09","conditions":["Hepatocellular Carcinoma"],"enrollment":110,"completionDate":"2021-10-30"},{"nctId":"NCT04961775","phase":"","title":"A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer","status":"UNKNOWN","sponsor":"Chinese PLA General Hospital","startDate":"2020-10-01","conditions":["Endometrial Carcinoma Stage I"],"enrollment":277,"completionDate":"2021-08-01"},{"nctId":"NCT04494022","phase":"NA","title":"Role of CEUS as a Secondary Diagnostic Modality","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2020-06-08","conditions":["Hepatocellular Carcinoma"],"enrollment":120,"completionDate":"2021-12-31"},{"nctId":"NCT02737865","phase":"NA","title":"Superb Microvascular Imaging in Focal Nodular Hyperplasia","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2016-05","conditions":["Focal Nodular Hyperplasia"],"enrollment":62,"completionDate":"2019-04-25"},{"nctId":"NCT04006275","phase":"PHASE3","title":"Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2019-06-30","conditions":["Hepatocellular Carcinoma","Cirrhosis"],"enrollment":100,"completionDate":"2019-12-30"},{"nctId":"NCT02188901","phase":"NA","title":"Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-10-15","conditions":["Hepatocellular Carcinoma (HCC)"],"enrollment":523,"completionDate":"2016-08-03"},{"nctId":"NCT03340870","phase":"PHASE1","title":"A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers","status":"COMPLETED","sponsor":"GE Healthcare","startDate":"2014-10-20","conditions":["Healthy"],"enrollment":16,"completionDate":"2014-11-20"},{"nctId":"NCT00669851","phase":"PHASE3","title":"Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study","status":"COMPLETED","sponsor":"Acusphere","startDate":"2006-11","conditions":["Coronary Artery Disease"],"enrollment":39,"completionDate":"2007-03"},{"nctId":"NCT00670332","phase":"","title":"Prognostic Assessment of Contrast Echocardiography (PACE Study)","status":"TERMINATED","sponsor":"Acusphere","startDate":"2007-07","conditions":["Coronary Artery Disease"],"enrollment":773,"completionDate":""},{"nctId":"NCT00156780","phase":"PHASE1","title":"Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF","status":"COMPLETED","sponsor":"Acusphere","startDate":"2004-08","conditions":["Congestive Heart Failure","Chronic Obstructive Pulmonary Disease"],"enrollment":0,"completionDate":"2005-07"},{"nctId":"NCT00156845","phase":"PHASE3","title":"Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography","status":"COMPLETED","sponsor":"Acusphere","startDate":"2003-12","conditions":["Coronary Artery Disease"],"enrollment":450,"completionDate":"2006-06"},{"nctId":"NCT00156793","phase":"PHASE3","title":"Phase 3 Imaging and Safety Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing SPECT Imaging","status":"COMPLETED","sponsor":"Acusphere","startDate":"2003-12","conditions":["Coronary Artery Disease"],"enrollment":400,"completionDate":"2006-03"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"018502","UNII":"SE4TWR0K2C","CHEBI":"CHEBI:134964","INN_ID":"8465","UMLSCUI":"C0665540","ChEMBL_ID":"CHEMBL2104979","KEGG_DRUG":"D05440","DRUGBANK_ID":"DB12821","PUBCHEM_CID":"9638","SNOMEDCT_US":"418334003","MESH_SUPPLEMENTAL_RECORD_UI":"C108042"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Respiratory"],"atcClassification":{"source":"DrugCentral","atcCode":"V08DA06","allCodes":["V08DA06"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 23","pmid":"41574786","title":"Efficacy of Contrast-Enhanced Endoscopic Ultrasound in the Diagnosis of Gallbladder Tumor: A Retrospective Multicenter Cohort Study.","journal":"Journal of hepato-biliary-pancreatic sciences"},{"date":"2026 Jan 1","pmid":"41515615","title":"Primary Hepatic Squamous Cell Carcinoma.","journal":"Diagnostics (Basel, Switzerland)"},{"date":"2025","pmid":"41371675","title":"[Diffuse intrahepatic cholangiocarcinoma with diverse imaging findings].","journal":"Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology"},{"date":"2025 Aug 5","pmid":"40764793","title":"Perfluorobutane CEUS for early-stage cervical lymphoma: diagnostic value of the postvascular phase starfield sign.","journal":"Scientific reports"},{"date":"2025 Aug","pmid":"40437838","title":"Differentiating between hepatocellular carcinoma and its mimickers using contrast-enhanced ultrasound with perflubutane microbubbles.","journal":"Expert review of medical devices"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"withdrawn","approval_date":"2014-08-28T00:00:00.000Z","mah":"Acusphere Ltd","brand_name_local":"Imagify","application_number":"EMEA/H/C/002347"}],"trialStats":{"total":9,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:38:26.046815+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}